FdaApplication

NDA 022074

Back to search

Identifiers

Properties

PropertyValue
applicant_nameIPSEN PHARMA BIOTECH SAS
application_typeNDA
approval_date2007-08-30

Products (3)

ProductActive ingredientStrengthDosage form
SOMATULINE DEPOTLANREOTIDE ACETATEEQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML)SOLUTION;SUBCUTANEOUS
SOMATULINE DEPOTLANREOTIDE ACETATEEQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML)SOLUTION;SUBCUTANEOUS
SOMATULINE DEPOTLANREOTIDE ACETATEEQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML)SOLUTION;SUBCUTANEOUS

3 products